产品编号 :
Cas No. :
CAS No. |
1333218-50-0 |
|---|---|
中文名称 |
(S)-2-氨基-3-[3-(3-氯-2-甲基-5-磺基苯基)脲基]丙酸 |
英文名称 |
(S)-2-Amino-3-(3-(3-chloro-2-methyl-5-sulfophenyl)ureido)propanoic acid |
别名 |
5C1222PBE2 | upasita | (2S)-2-amino-3-{[(3-chloro-2-methyl-5-sulfophenyl)carbamoyl]amino}propanoic acid | GLXC-26510 | LHEYGVSDVBEYQF-QMMMGPOBSA-N | HY-109106 | L-Alanine, 3-((((3-chloro-2-methyl-5-sulfophenyl)amino)carbonyl)amino)- | UPACICALCET [WHO-DD] |
标准英文名 |
(S)-2-amino-3-(3-(3-chloro-2-methyl-5-sulfophenyl)ureido)propanoic acid |
分子式 |
C11H14ClN3O6S |
分子量 |
351.77 |
精确分子量 |
351.03 |
SMILES |
N[C@@H](CNC(NC1=CC(S(=O)(O)=O)=CC(Cl)=C1C)=O)C(O)=O |
标准SMILES |
CC1=C(Cl)C=C(C=C1NC(=O)NC[C@H](N)C(O)=O)S(O)(=O)=O |
用途 |
Upacicalcet is a calcimimetic agent used for the treatment of secondary hyperparathyroidism (SHPT) in patients undergoing dialysis; it acts by directly activating the calcium-sensing receptor on parathyroid cells to suppress excessive parathyroid hormone (PTH) secretion, thereby reducing serum PTH levels. |
InChIKey |
LHEYGVSDVBEYQF-QMMMGPOBSA-N |
|
|
评论 |
|---|